S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Bio-Techne (TECH) Short Interest Ratio & Short Volume

$62.12
-0.09 (-0.14%)
(As of 04/19/2024 08:51 PM ET)

Bio-Techne Short Interest Data

Current Short Volume
5,320,000 shares
Previous Short Volume
5,100,000 shares
Change Vs. Previous Month
+4.31%
Dollar Volume Sold Short
$374.47 million
Short Interest Ratio / Days to Cover
5.0
Last Record Date
March 31, 2024
Outstanding Shares
157,190,000 shares
Percentage of Shares Shorted
3.38%
Today's Trading Volume
909,600 shares
Average Trading Volume
1,069,561 shares
Today's Volume Vs. Average
85%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Bio-Techne ?

Sign up to receive the latest short interest report for Bio-Techne and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TECH Short Interest Over Time

TECH Days to Cover Over Time

TECH Percentage of Float Shorted Over Time

Bio-Techne Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20245,320,000 shares $374.47 million +4.3%N/A5 $70.39
3/15/20245,100,000 shares $369.85 million +11.4%N/A4.9 $72.52
2/29/20244,580,000 shares $336.95 million -3.2%N/A4.2 $73.57
2/15/20244,730,000 shares $337.06 million +42.5%N/A4.4 $71.26
1/31/20243,320,000 shares $233.46 million -17.8%N/A2.9 $70.32
1/15/20244,040,000 shares $291.57 million -17.2%N/A3.3 $72.17
12/31/20234,880,000 shares $376.54 million -2.8%N/A4.1 $77.16
12/15/20235,020,000 shares $381.47 million +39.1%N/A4.2 $75.99
11/30/20233,610,000 shares $227.07 million +24.5%N/A3.2 $62.90
11/15/20232,900,000 shares $176.58 million -10.5%N/A2.7 $60.89
10/31/20233,240,000 shares $177.00 million -5.0%N/A3.2 $54.63
10/15/20233,410,000 shares $231.16 million -7.8%N/A4 $67.79
9/30/20233,700,000 shares $251.86 million +7.6%N/A4.5 $68.07
9/15/20233,440,000 shares $253.36 million +11.0%N/A4.2 $73.65
8/31/20233,100,000 shares $243.04 million -1.3%N/A3.6 $78.40
8/15/20233,140,000 shares $265.68 million +7.2%N/A3.6 $84.61
7/31/20232,930,000 shares $244.36 million -7.0%N/A3.2 $83.40
7/15/20233,150,000 shares $265.29 million +14.1%N/A3.2 $84.22
6/30/20232,760,000 shares $225.30 million -8.0%N/A2.6 $81.63
6/15/20233,000,000 shares $229.83 million -1.3%N/A2.8 $76.61
5/31/20233,040,000 shares $248.64 million +1.3%N/A3 $81.79
5/15/20233,000,000 shares $243.24 million +7.9%N/A2.8 $81.08
4/30/20232,780,000 shares $222.07 million -25.9%N/A2.6 $79.88
4/15/20233,750,000 shares $319.65 million +55.6%N/A3.6 $85.24
3/31/20232,410,000 shares $178.80 million -6.6%N/A2.4 $74.19
3/15/20232,580,000 shares $187.75 million +0.8%N/A2.7 $72.77
2/28/20232,560,000 shares $185.96 million +16.4%N/A2.6 $72.64
2/15/20232,200,000 shares $168.96 million -19.1%N/A2.3 $76.80
1/31/20232,720,000 shares $216.68 million +19.3%N/A2.6 $79.66
1/15/20232,280,000 shares $184.34 million -3.4%N/A2.1 $80.85
12/30/20222,360,000 shares $195.60 million -3.7%N/A2.2 $82.88
12/15/20222,450,000 shares $206.27 million +3.8%N/A2 $84.19
11/30/20222,360,000 shares $200.58 million +210.1%N/A1.9 $84.99
11/15/2022761,100 shares $268.13 million +9.4%2.0%2.5 $352.29
10/31/2022695,500 shares $206.05 million +2.8%1.8%2.4 $296.26
10/15/2022676,500 shares $191.35 million -3.1%1.8%2.7 $282.86
9/30/2022697,900 shares $198.20 million -0.4%1.8%2.8 $284.00
9/15/2022700,500 shares $221.62 million +25.0%1.8%3.3 $316.37
8/31/2022560,400 shares $185.95 million +1.6%1.5%2.5 $331.81
8/15/2022551,700 shares $208.59 million -26.9%1.4%2.5 $378.08
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

TECH Short Interest - Frequently Asked Questions

What is Bio-Techne's current short interest?

Short interest is the volume of Bio-Techne shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 5,320,000 shares of TECH short. Learn More on Bio-Techne's current short interest.

What is a good short interest ratio for Bio-Techne?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TECH shares currently have a short interest ratio of 5.0. Learn More on Bio-Techne's short interest ratio.

Which institutional investors are shorting Bio-Techne?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Techne: Parallax Volatility Advisers L.P., Citadel Advisors LLC, PEAK6 Investments LLC, Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Bio-Techne's short interest increasing or decreasing?

Bio-Techne saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,320,000 shares, an increase of 4.3% from the previous total of 5,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Bio-Techne's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Bio-Techne: Repligen Co. (9.18%), Qiagen (1.62%), Exelixis, Inc. (2.32%), Neurocrine Biosciences, Inc. (2.44%), Vaxcyte, Inc. (7.59%), Revolution Medicines, Inc. (7.29%), CRISPR Therapeutics AG (17.39%), Halozyme Therapeutics, Inc. (6.28%), Krystal Biotech, Inc. (7.61%), Immunovant, Inc. (14.92%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Bio-Techne stock?

Short selling TECH is an investing strategy that aims to generate trading profit from Bio-Techne as its price is falling. TECH shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bio-Techne?

A short squeeze for Bio-Techne occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TECH, which in turn drives the price of the stock up even further.

How often is Bio-Techne's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TECH, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TECH) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners